Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-09-16

Clinical Trial Update: Islet After Kidney Transplant for Type 1 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update notes that the Phase 1/2 Islet After Kidney Transplant for Type 1 Diabetes trial has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Type 1 Diabetes Mellitus | Phase 1, Phase 2 | Status: WITHDRAWN